Johan Szamosi, MSc
- 2Articles
- 12KReads1
- 2009–2014Active
- 8Collaborators
- 182Citations2
About
Johan Szamosi, MSc, has published research focused on major depressive disorder (MDD) and suicidality, particularly examining the use of extended-release quetiapine fumarate. His work includes clinical studies evaluating quetiapine both as monotherapy and as an adjunct to antidepressants in patients with MDD. Szamosi's publications, appearing between 2009 and 2014, contribute to the clinical understanding of treatment options for depression and associated suicidal risk.
Publications
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
